144 related articles for article (PubMed ID: 7105517)
21. Adjuvant chemotherapy in the primary management of breast cancer.
Fisher B
Med Clin North Am; 1977 Sep; 61(5):953-65. PubMed ID: 330977
[No Abstract] [Full Text] [Related]
22. Multimodal therapy for histological stage-II breast cancer. Multicentre Breast Cancer Chemotherapy Group.
Lancet; 1977 Aug; 2(8034):396-7. PubMed ID: 70600
[No Abstract] [Full Text] [Related]
23. Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
Bezwoda WR; Derman DP; Browde S; Goss G; Lange M
S Afr Med J; 1984 Sep; 66(10):372-4. PubMed ID: 6484759
[TBL] [Abstract][Full Text] [Related]
24. Editorial: Major advance in breast-cancer therapy.
Holland JF
N Engl J Med; 1976 Feb; 294(8):440-1. PubMed ID: 1246311
[No Abstract] [Full Text] [Related]
25. Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy.
Bitran JD; Desser RK; Shapiro CM; Michel A; Kozloff MF; Billings AA; Recent W
Cancer; 1983 Feb; 51(3):381-4. PubMed ID: 6821824
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
Gargan TJ; Come SE; Satwicz PR
Plast Reconstr Surg; 1985 Mar; 75(3):430-4. PubMed ID: 3919414
[No Abstract] [Full Text] [Related]
27. Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
Bianco AR; De Placido S; Perrone F; Carlomagno C; De Laurentiis M; Del Mastro L; Lauria R; Marinelli A; Gallo C
Ann N Y Acad Sci; 1993 Nov; 698():330-8. PubMed ID: 8279772
[No Abstract] [Full Text] [Related]
28. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
29. Chemotherapy in the treatment strategy of breast cancer.
Carbone PP
Cancer; 1975 Aug; 36(2):633-7. PubMed ID: 1157025
[TBL] [Abstract][Full Text] [Related]
30. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
[TBL] [Abstract][Full Text] [Related]
31. [Adjuvant chemotherapy in operable breast cancer].
Senn HJ
Dtsch Med Wochenschr; 1984 Jun; 109(26):1034-43. PubMed ID: 6734462
[No Abstract] [Full Text] [Related]
32. [Hormone therapy of patients with breast cancer].
Moiseenko VM; Semiglazov VF
Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
[No Abstract] [Full Text] [Related]
33. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
[TBL] [Abstract][Full Text] [Related]
35. The current status of systemic adjuvant therapy in the management of primary breast cancer.
Fisher B; Wolmark N
Surg Clin North Am; 1981 Dec; 61(6):1347-60. PubMed ID: 7031938
[No Abstract] [Full Text] [Related]
36. [Value of hormone therapy in metastasizing breast cancer].
Samonigg H
Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
[TBL] [Abstract][Full Text] [Related]
37. Favorable factors in the adjuvant therapy of breast cancer.
Carpenter JT; Maddox WA; Laws HL; Wirtschafter DD; Soong SJ
Cancer; 1982 Jul; 50(1):18-23. PubMed ID: 7044517
[TBL] [Abstract][Full Text] [Related]
38. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
Heuson JC; Sylvester R; Engelsman E
Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
[No Abstract] [Full Text] [Related]
39. Symposium on breast carcinoma.
Weinrach RS
Ariz Med; 1975 Apr; 32(4):299-302. PubMed ID: 1119949
[No Abstract] [Full Text] [Related]
40. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG
J Natl Cancer Inst; 1997 Nov; 89(22):1673-82. PubMed ID: 9390536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
